Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: Drug: EDG-15400 25 mg; Drug: Placebo to match EDG-15400 25 mg or 50 mg; Drug: EDG-15400 50 mg
Sponsors: Edgewise Therapeutics, Inc.
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
